Literature DB >> 17641518

The promise of stereotactic body radiation therapy in a new era of oncology.

Brian D Kavanagh1, Karen Kelly, Madeleine Kane.   

Abstract

The fusion of state-of-the-art tumor imaging with precision radiation treatment delivery systems provides the technical platform from which stereotactic body radiation therapy (SBRT) has arisen. SBRT offers an opportunity to depart from classic radiation therapy paradigms involving many weeks of treatment toward more efficient and more potent treatment schedules in a variety of clinical settings. Here, the history of SBRT is briefly reviewed, and a projection of the anticipated role of SBRT within the context of multimodality cancer treatment regimens of the future is presented.

Entities:  

Mesh:

Year:  2007        PMID: 17641518     DOI: 10.1159/000106045

Source DB:  PubMed          Journal:  Front Radiat Ther Oncol        ISSN: 0071-9676


  3 in total

Review 1.  Rationale for ablation of oligometastatic disease and the role of stereotactic body radiation therapy for hepatic metastases.

Authors:  Chad G Rusthoven; Tracey E Schefter
Journal:  Hepat Oncol       Date:  2013-12-20

Review 2.  Risk factors and management of oligometastatic non-small cell lung cancer.

Authors:  Akshar N Patel; Charles B Simone; Salma K Jabbour
Journal:  Ther Adv Respir Dis       Date:  2016-04-08       Impact factor: 4.031

3.  Three discipline collaborative radiation therapy (3DCRT) special debate: The single most important factor in determining the future of SBRT is immune response.

Authors:  Clemens Grassberger; Kathryn Huber; Naduparambil K Jacob; Michael D Green; Peter Mahler; Joann Prisciandaro; Michael Dominello; Michael C Joiner; Jay Burmeister
Journal:  J Appl Clin Med Phys       Date:  2019-10-01       Impact factor: 2.102

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.